FAM72A and cancer: Our data pave the way for new investigative experimental approaches to validate the prevention of cancer by interfering with the FAM72A-UNG2 signaling pathways using withaferin B. Withaferin B is a potential candidate for future investigations in the interference with genome stability, centromere formation, and genome editing, and on potential therapeutic strategies for the treatment of cancer.